Inactive Instrument

News Wockhardt Bio AG

Equities

Wockhardt Bio : Ad hoc Announcement pursuant to Art.16 Para 4. Listing Rules	23-06-30	PU
Wockhardt Bio AG Reports Earnings Results for the Full Year Ended March 31, 2022	22-07-12	CI
Wockhardt Bio Ag and Jiangxi Jemincare Group Company Limited, China ("Jemincare"), Partnered for Wockhardt's Novel Patented Antibiotic Wck 4873	21-08-25	CI
Wockhardt Bio AG Reports Earnings Results for the Full Year Ended March 31, 2021	21-06-07	CI
Wockhardt Bio AG Announces Audited Earnings Results for the Year Ended March 31, 2020	20-07-05	CI
Wockhardt Ltd. cancelled the acquisition of Wockhardt France S.A.S. from Wockhardt Bio AG.	17-11-09	CI
Wockhardt Ltd. agreed to acquire Wockhardt France S.A.S. from Wockhardt Bio AG.	16-11-09	CI
Wockhardt Bio AG Avails Secure Term Loan of $250 Million Facility	16-07-01	CI
Wockhardt Bio AG has completed an IPO in the amount of CHF 11.8574 million.	13-12-18	CI

No results for this search